The Readout Loud cover image

393: A conversation with the 'godfather' of biotech

The Readout Loud

00:00

Structure Therapeutics' amylin drug results and caveats

Elaine Chen summarizes Structure's phase 2 amylin data, highlighting 16% on-treatment weight loss and high discontinuation concerns.

Play episode from 01:03
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app